サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：抗ヒスタミン剤の世界市場（2022年～2028年）
市場調査レポート
商品コード
1215696

抗ヒスタミン剤の世界市場（2022年～2028年）

Antihistamine Drugs Market 2022-2028
出版日: | 発行: Orion Market Research | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
抗ヒスタミン剤の世界市場（2022年～2028年）
出版日: 2023年01月14日
発行: Orion Market Research
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の抗ヒスタミン剤の市場規模は、予測期間中に8.7%という大幅なCAGRで成長すると予測されています。抗ヒスタミン剤の世界市場は、主に医療費の増加や、ヘルスケア分野における新たな技術投資に対する高い需要といった要因によって牽引されています。さらに、様々なアレルギー疾患を治療するための診断方法の増加や、治療法の利用可能性に関する認知率の向上も、市場成長を促進する顕著な要因となっています。

当レポートでは、世界の抗ヒスタミン剤市場について調査し、市場の概要とともに、競合情勢、セグメント別の市場、地域別分析、および企業プロファイルなどを提供しています。

目次

第1章 レポートの概要

第2章 市場概要と考察

  • 調査範囲
  • アナリストによる考察と現在の市場動向

第3章 競合情勢

  • 主要企業分析
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • 主要戦略分析

第4章 市場決定要因

  • 促進要因
  • 抑制要因
  • 機会

第5章 市場セグメンテーション

  • 世界の抗ヒスタミン薬市場：タイプ別
    • H-1受容体拮抗薬
    • H-2受容体拮抗薬
  • 世界の抗ヒスタミン薬市場：用途別
    • インフルエンザ・風邪
    • アレルギー
    • 皮膚炎
    • 蕁麻疹
    • その他
  • 世界の抗ヒスタミン薬市場：エンドユーザー別
    • 在宅ケア
    • 病院・診療所
    • その他（ACS）

第6章 地域分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他欧州
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • その他の地域
    • ラテンアメリカ
    • 中東・アフリカ

第7章 企業プロファイル

  • Akorn, Inc.
  • Almirall S.A.
  • AstraZeneca PLC
  • Bayer AG
  • Boehringer Ingelheim International GmbH.
  • Bristol-Myers Squibb Co.
  • Cadila Pharmaceuticals, Ltd.
  • F. Hoffmann-La Roche, Ltd.
  • GlaxoSmithKline PLC
  • Johnson & Johnson Services, Ltd.
  • Meda Consumer Healthcare, Inc.
  • Merck & Co.
  • Mylan N.V.
  • Novartis International AG
  • Pfizer, Inc.
図表

LIST OF TABLES

  • 1. GLOBAL ANTIHISTAMINE DRUGS MARKET RESEARCH AND ANALYSIS BY DRUG TYPE, 2021-2028 ($ MILLION)
  • 2. GLOBAL H-1 RECEPTOR ANTAGONISTS DRUGS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 3. GLOBAL H-1 RECEPTOR ANTAGONISTS DRUGS MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 4. GLOBAL H-2 RECEPTOR ANTAGONISTS DRUGS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 5. GLOBAL H-2 RECEPTOR ANTAGONISTS DRUGS MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 6. GLOBAL BROMPHENIRAMINE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 7. GLOBAL DIPHENHYDRAMINE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 8. GLOBAL CETIRIZINE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 9. GLOBAL DESLORATADINE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 10. GLOBAL LORATADINE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 11. GLOBAL FEXOFENADINE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 12. GLOBAL OTHERS H-1 RECEPTOR ANTAGONISTS DRUG MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 13. GLOBAL CIMETIDINE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 14. GLOBAL FAMOTIDINE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 15. GLOBAL NIZATIDINE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 16. GLOBAL RANITIDINE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 17. OTHER H-2 RECEPTOR ANTAGONISTS DRUG MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 18. GLOBAL ANTIHISTAMINE DRUGS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
  • 19. GLOBAL ANTIHISTAMINE DRUGS IN ALLERGY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 20. GLOBAL ANTIHISTAMINE DRUGS IN FLU AND COLD MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 21. GLOBAL ANTIHISTAMINE DRUGS IN DERMATITIS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 22. GLOBAL ANTIHISTAMINE DRUGS IN URTICARIA MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 23. GLOBAL ANTIHISTAMINE DRUGS IN OTHERS APPLICATIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 24. GLOBAL ANTIHISTAMINE DRUGS MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
  • 25. GLOBAL ANTIHISTAMINE DRUGS FOR HOMECARE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 26. GLOBAL ANTIHISTAMINE DRUGS FOR HOSPITALS AND CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 27. GLOBAL ANTIHISTAMINE DRUGS FOR OTHERS END-USER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 28. GLOBAL ANTIHISTAMINE DRUGS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 29. NORTH AMERICAN ANTIHISTAMINE DRUGS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 30. NORTH AMERICAN ANTIHISTAMINE DRUGS MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 31. NORTH AMERICAN ANTIHISTAMINE DRUGS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
  • 32. NORTH AMERICAN ANTIHISTAMINE DRUGS MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
  • 33. EUROPEAN ANTIHISTAMINE DRUGS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 34. EUROPEAN ANTIHISTAMINE DRUGS MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 35. EUROPEAN ANTIHISTAMINE DRUGS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
  • 36. EUROPEAN ANTIHISTAMINE DRUGS MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
  • 37. ASIA-PACIFIC ANTIHISTAMINE DRUGS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 38. ASIA-PACIFIC ANTIHISTAMINE DRUGS MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 39. ASIA-PACIFIC ANTIHISTAMINE DRUGS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
  • 40. ASIA-PACIFIC ANTIHISTAMINE DRUGS MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
  • 41. REST OF THE WORLD ANTIHISTAMINE DRUGS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 42. REST OF THE WORLD ANTIHISTAMINE DRUGS MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 43. REST OF THE WORLD ANTIHISTAMINE DRUGS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
  • 44. REST OF THE WORLD ANTIHISTAMINE DRUGS MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL ANTIHISTAMINE DRUGS MARKET SHARE BY TYPE, 2021 VS 2028 (%)
  • 2. GLOBAL ANTIHISTAMINE DRUGS MARKET SHARE BY APPLICATION, 2021 VS 2028 (%)
  • 3. GLOBAL ANTIHISTAMINE DRUGS MARKET SHARE BY END-USER, 2021 VS 2028 (%)
  • 4. GLOBAL ANTIHISTAMINE DRUGS MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 5. GLOBAL H-1 RECEPTOR ANTAGONISTS DRUGS MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 6. GLOBAL H-1 RECEPTOR ANTAGONISTS DRUGS MARKET SHARE BY TYPE, 2021 VS 2028 (%)
  • 7. GLOBAL H-2 RECEPTOR ANTAGONISTS DRUGS MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 8. GLOBAL H-2 RECEPTOR ANTAGONISTS DRUGS MARKET SHARE BY TYPE, 2021 VS 2028 (%)
  • 9. GLOBAL BROMPHENIRAMINE MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 10. GLOBAL DIPHENHYDRAMINE MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 11. GLOBAL CETIRIZINE MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 12. GLOBAL DESLORATADINE MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 13. GLOBAL LORATADINE MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 14. GLOBAL FEXOFENADINE MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 15. GLOBAL OTHERS H-1 RECEPTOR ANTAGONISTS DRUG MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 16. GLOBAL CIMETIDINE MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 17. GLOBAL FAMOTIDINE MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 18. GLOBAL NIZATIDINE MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 19. GLOBAL RANITIDINE MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 20. OTHER H-2 RECEPTOR ANTAGONISTS DRUG MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 21. GLOBAL ANTIHISTAMINE DRUGS MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 22. GLOBAL ANTIHISTAMINE DRUGS IN ALLERGY MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 23. GLOBAL ANTIHISTAMINE DRUGS IN FLU AND COLD MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 24. GLOBAL ANTIHISTAMINE DRUGS IN DERMATITIS MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 25. GLOBAL ANTIHISTAMINE DRUGS IN URTICARIA MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 26. GLOBAL ANTIHISTAMINE DRUGS FOR HOMECARE MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 27. GLOBAL ANTIHISTAMINE DRUGS FOR HOSPITALS AND CLINICS MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 28. GLOBAL ANTIHISTAMINE DRUGS FOR OTHERS END-USER MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 29. US ANTIHISTAMINE DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
  • 30. CANADA ANTIHISTAMINE DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
  • 31. UK ANTIHISTAMINE DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
  • 32. FRANCE ANTIHISTAMINE DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
  • 33. GERMANY ANTIHISTAMINE DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
  • 34. ITALY ANTIHISTAMINE DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
  • 35. SPAIN ANTIHISTAMINE DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
  • 36. REST OF EUROPE ANTIHISTAMINE DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
  • 37. INDIA ANTIHISTAMINE DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
  • 38. CHINA ANTIHISTAMINE DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
  • 39. JAPAN ANTIHISTAMINE DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
  • 40. SOUTH KOREA ANTIHISTAMINE DRUGS MARKET SIZE, 2021-2028 ($ MILLION)
  • 41. REST OF ASIA-PACIFIC ANTIHISTAMINE DRUGS MARKET SIZE, 2021-2028 ($ MILLION)

42. REST OF THE WORLD ANTIHISTAMINE DRUGS MARKET SIZE, 2021-2027($ MILLION

目次
Product Code: OMR2026752

Title:Global Antihistamine Drugs Market Size, Share, and Trends Analysis Report, by Drug Type (H-1 Receptor Antagonist and H-2 Receptor Antagonists), by Application (Flu and Cold, Allergy, Dermatitis, Urticaria, and Others), by End-User (Homecare, Hospitals and Clinics, and Others), Forecast Period (2022-2028).

The global antihistamine drugs market is anticipated to grow at a substantial CAGR of 8.7% during the forecast period. The global antihistamine drugs market is primarily driven by the factors such as rising healthcare expenditure and the high demand for new technological investment in the healthcare sector. Moreover, increasing diagnostic methods to treat various allergic diseases and the growing rate of awareness about the availability of treatments are the other prominent factors that have broken the market growth. For instance, FARE, one of the largest private funders of food allergy research, promotes the development of new therapies and offers hope for effective treatments. Similarly, in March 2022, around $26.9 million investment into allergy prevention and management was announced by the Centre for Food & Allergy Research (CFAR) under the 2022 federal government budget. Such initiatives are projected to bring new growth opportunities to the market.

The global antihistamine drugs market is segmented based on drug type, application, and end-user. Based on drug type, the market is sub-segmented into H-1 receptor antagonists (including, brompheniramine, diphenhydramine, cetirizine, desloratadine, loratadine, fexofenadine, and others) and H-2 receptor antagonists (including, cimetidine, famotidine, nizatidine, ranitidine, and other). Based on application, it is further classified into flu and cold, allergy, dermatitis, urticaria, and others. Among these, the allergy segment is projected to show promising growth during the forecasted period. The segment growth is driven by the factors such as the rising prevalence of allergic rhinitis which has further surged the other problems such as asthma, sinus, or ear conditions due to which the demand for the antihistamine drugs is considerably high. Moreover, allergic rhinitis therapies under development are focused on novel approaches to treat/improve diseased conditions. This can lead to the generation of new growth opportunities in the market. Similarly, based on end-user, the global antihistamine drugs market is categorized into home care, hospitals and clinics, and others.

Geographically, the antihistamine drugs are segmented into North America, Europe, Asia-Pacific, and the Rest of the World. A large amount of R&D expenditure for the development of allergy treatment, the rising prevalence of food allergies, and huge healthcare investments are expected to drive the antihistamine drugs market growth in the North American region. Europe is anticipated to be the second-fastest-growing market followed by the Asia-Pacific market. The growing awareness about perennial allergic rhinitis and the availability of good treatment options in the market can aid in the market growth in the respective regions.

The major market players in the global antihistamine drugs include Johnson & Johnson Services Ltd., Sanofi SA, Bayer AG, Novartis International AG, AstraZeneca PLC, GlaxoSmithKline PLC, Pfizer Inc., and Merck & Co., among others. The market players are also contributing significantly to the growth of the market by the adoption of various strategies including mergers and acquisitions, geographical expansion, partnerships, collaborations, and new product launches, to stay competitive in the market.

Research Methodology

The market study of the global antihistamine drugs market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to break down the market into various segments, and derive the total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macroeconomic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market.
  • Whitepapers, research papers, and news blogs.
  • Company websites and their product catalog.

The report provides an in-depth analysis of the market size and intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

  • Global Antihistamine Drugs Research and Analysis by Drug Type
  • Global Antihistamine Drugs Research and Analysis by Application
  • Global Antihistamine Drugs Research and Analysis by End-User

The Report Covers:

  • Comprehensive research methodology of the global antihistamine drugs market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global antihistamine drugs market.
  • Insights about market determinants that are stimulating the global antihistamine drugs market.
  • Detailed and extensive market segments with the regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • Impact of COVID-19 on the Global Antihistamine Drugs Industry
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
    • 3.1.1. Overview
    • 3.1.2. Financial Analysis
    • 3.1.3. SWOT Analysis
    • 3.1.4. Recent Developments
  • 3.2. Key Strategy Analysis

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global Antihistamine Drugs Market by Type
    • 5.1.1. H-1 Receptor Antagonist
      • 5.1.1.1. Brompheniramine
      • 5.1.1.2. Diphenhydramine
      • 5.1.1.3. Cetirizine
      • 5.1.1.4. Desloratadine
      • 5.1.1.5. Loratadine
      • 5.1.1.6. Fexofenadine
      • 5.1.1.7. Others
    • 5.1.2. H-2 Receptor Antagonists
      • 5.1.2.1. Cimetidine
      • 5.1.2.2. Famotidine
      • 5.1.2.3. Nizatidine
      • 5.1.2.4. Ranitidine
      • 5.1.2.5. Other
  • 5.2. Global Antihistamine Drugs Market by Application
    • 5.2.1. Flu and Cold
    • 5.2.2. Allergy
    • 5.2.3. Dermatitis
    • 5.2.4. Urticaria
    • 5.2.5. Others
  • 5.3. Global Antihistamine Drugs Market by End-User
    • 5.3.1. Homecare
    • 5.3.2. Hospitals and Clinics
    • 5.3.3. Others (ACS)

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. South Korea
    • 6.3.5. Rest of Asia-Pacific
  • 6.4. Rest of the World
    • 6.4.1. Latin America
    • 6.4.2. Middle East & Africa

7. Company Profiles

  • 7.1. Akorn, Inc.
  • 7.2. Almirall S.A.
  • 7.3. AstraZeneca PLC
  • 7.4. Bayer AG
  • 7.5. Boehringer Ingelheim International GmbH.
  • 7.6. Bristol-Myers Squibb Co.
  • 7.7. Cadila Pharmaceuticals, Ltd.
  • 7.8. F. Hoffmann-La Roche, Ltd.
  • 7.9. GlaxoSmithKline PLC
  • 7.10. Johnson & Johnson Services, Ltd.
  • 7.11. Meda Consumer Healthcare, Inc.
  • 7.12. Merck & Co.
  • 7.13. Mylan N.V.
  • 7.14. Novartis International AG
  • 7.15. Pfizer, Inc.